Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disorders: Addressing Unmet Needs with Emerging Therapies
| Overview / Abstract: |
In this Hematology Dialogues, Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disorders: Addressing Unmet Needs with Emerging Therapies, participants will learn about the epidemiology and burden of Epstein-Barr Virus-positive (EBV+) and post-transplant lymphoproliferative disorders (PTLD), differentiate between current and emerging prognostic scoring systems for EBV+ and PTLD to inform treatment decisions, and evaluate the latest clinical evidence of emerging treatment options for EBV+ and PTLD. Experts will discuss hot topics in the field of EBV+ and PTLD as well as respond to patient cases and provide commentary relating to how they have responded to complex treatment decisions, thereby ensuring optimal clinical outcomes. This independent satellite symposium is derived from the Society of Hematologic Oncology 2024 Annual Meeting, originally held on September 5, 2024. |
|
Expiration |
Sep 24, 2025 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
1.0 |
|
Accreditation |
ACCME, EBAH, AAPA, NCPD, ILNA, ABIM MOC |
|
Presenters / Authors / Faculty |
Kris M. Mahadeo, MD, MPH Timothy Voorhees, MD, MSCR Sarah Featherston, RN, CPN, BMTCN |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Pierre Fabre. In-Kind support provided by National Marrow Donor Program (NMDP) and American Society for Transplantation and Cellular Therapy (ASTCT). |
|
Keywords / Search Terms |
Medical Learning Institute, Inc. SOHO, oncology, hematologic oncology, hemeonc, hemonc, hematology, hematology oncology, hemonc NP, hemonc nurse, oncology nursing, oncology NP, oncology PA, epstein-barr virus, EBV+, PTLD, Post-Transplant Lymphoproliferative Disorders, Lymphoproliferative Disorders, EBAH, blood cancers Free CE CME |
|